Takeda to end collaboration with Orexigen

Takeda Pharmaceutical has informed Orexigen Therapeutics Inc. (Nasdaq: OREX) that Takeda will end their collaboration agreement sending the stock price tumbling 93 cents to $5.00.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.